Exploiting metabolic pathways to target tumors with effective therapeutics.
Our initial development programs are focused on oncology, specifically related to therapeutics.
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Lorem ipsum dolor sit amet, consectetur adipiscing elit
January Therapeutics is targeting cell-essential drivers of cancer which cannot be successfully drugged by chemistry alone. January’s technology exploits the dysregulated metabolic pathways in cancer and uses albumin to preferentially deliver drug to tumors while sparing healthy cells.
CEO
SAN DIEGO (PRWEB) November 05, 2021 January Therapeutics today announced the appointment of Terence Williams, MD, PhD as a Scientific Advisory Board Member. Dr. Williams
SAN DIEGO (PRWEB) AUGUST 05, 2021 January Therapeutics announced the appointment of Patrick Kearney, PhD, as Head of Early Research and Development. Dr. Kearney will
SAN DIEGO (PR WEB) MAY 5, 2021 Dr. Grint has served as the Executive Chairman of the Board of Directors of Cardea Bio since April
Sample Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod te mpor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel fa cilisis commodo viverra.